Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study

PURPOSE: Fibroblast growth factor 21 (FGF21) is a crucial metabolic regulator, with multiple favorable effects on glucose homeostasis and lipid metabolism. Since serum FGF21 level has been implicated as a potential marker for the early identification of metabolic syndrome (MetS), we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jung Ran, Kim, Jang-Young, Park, Il Hwan, Huh, Ji Hye, Kim, Ki Woo, Cha, Seung-Kuy, Park, Kyu-Sang, Sohn, Joon Hyung, Park, Jong Taek, Koh, Sang Baek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823832/
https://www.ncbi.nlm.nih.gov/pubmed/29436198
http://dx.doi.org/10.3349/ymj.2018.59.2.287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823832/
https://www.ncbi.nlm.nih.gov/pubmed/29436198
http://dx.doi.org/10.3349/ymj.2018.59.2.287

Ejemplares similares